[Skip to Content]
[Skip to Content Landing]
Citations 0
Letters
July 14, 1999

Gabapentin for Postherpetic Neuralgia

JAMA. 1999;282(2):134-135. doi:10-1001/pubs.JAMA-ISSN-0098-7484-282-2-jbk0714

To the Editor: Published clinical trial reports often fail to adequately document safety findings.1 In this respect, Dr Rowbotham and colleagues2 should be commended for providing detailed safety data in their study on the use of gabapentin for the treatment of postherpetic neuralgia.

First Page Preview View Large
First page PDF preview
First page PDF preview
×